AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
186.04
-0.64 (-0.34%)
Apr 29, 2026, 12:44 PM EDT - Market open
AstraZeneca Employees
AstraZeneca had 95,100 employees as of December 31, 2025. The number of employees increased by 2,200 or 2.37% compared to the previous year.
Employees
95,100
Change (1Y)
2,200
Growth (1Y)
2.37%
Revenue / Employee
$635,531
Profits / Employee
$109,243
Market Cap
291.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 95,100 | 2,200 | 2.37% |
| Dec 31, 2024 | 92,900 | 3,000 | 3.34% |
| Dec 31, 2023 | 89,900 | 6,400 | 7.66% |
| Dec 31, 2022 | 83,500 | 400 | 0.48% |
| Dec 31, 2021 | 83,100 | 7,000 | 9.20% |
| Dec 31, 2020 | 76,100 | 5,500 | 7.79% |
| Dec 31, 2019 | 70,600 | 6,000 | 9.29% |
| Dec 31, 2018 | 64,600 | 3,500 | 5.73% |
| Dec 31, 2017 | 61,100 | 1,400 | 2.35% |
| Dec 31, 2016 | 59,700 | -1,800 | -2.93% |
| Dec 31, 2015 | 61,500 | 4,000 | 6.96% |
| Dec 31, 2014 | 57,500 | 6,000 | 11.65% |
| Dec 31, 2013 | 51,500 | -200 | -0.39% |
| Dec 31, 2012 | 51,700 | -5,500 | -9.62% |
| Dec 31, 2011 | 57,200 | -3,800 | -6.23% |
| Dec 31, 2010 | 61,000 | -1,700 | -2.71% |
| Dec 31, 2009 | 62,700 | -2,300 | -3.54% |
| Dec 31, 2008 | 65,000 | -2,400 | -3.56% |
| Dec 31, 2007 | 67,400 | 600 | 0.90% |
| Dec 31, 2006 | 66,800 | 1,500 | 2.30% |
| Dec 31, 2005 | 65,300 | 1,100 | 1.71% |
| Dec 31, 2004 | 64,200 | 1,600 | 2.56% |
| Dec 31, 2003 | 62,600 | 3,400 | 5.74% |
| Dec 31, 2002 | 59,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| GSK plc | 66,841 |
| AbbVie | 57,000 |
AZN News
- 5 hours ago - AstraZeneca to make $405 million investment in Britain, PM Starmer says - Reuters
- 10 hours ago - AstraZeneca Gets Revenue Boost From Cancer Drugs - WSJ
- 10 hours ago - AstraZeneca beats profit expectations, keeps annual outlook unchanged - Reuters
- 20 hours ago - Guardant Health (GH) Faces Minimal Impact from AstraZeneca Advisory Meeting - GuruFocus
- 20 hours ago - Amgen (AMGN) and AstraZeneca (AZN) Launch Real-Time Clinical Trials with FDA - GuruFocus
- 20 hours ago - Pre-Market Earnings Report for April 29, 2026 : ABBV, AZN, TTE, APH, UBS, GD, ADP, REGN, CNI, PSX, ETR, GRMN - Nasdaq
- 21 hours ago - AstraZeneca (AZN) to Test AI-Driven Data Reporting in Clinical Trials - GuruFocus
- 1 day ago - Earnings To Watch: AstraZeneca PLC (LSE:AZN) Reports Q1 2026 Result - GuruFocus